<DOC>
	<DOCNO>NCT01670799</DOCNO>
	<brief_summary>The purpose study evaluate anti-cancer effect pain medication call ketorolac ( Toradol ) ovarian cancer cell abdominal ( peritoneal ) cavity surgery ovarian , fallopian tube primary peritoneal cancer .</brief_summary>
	<brief_title>Availability &amp; Effect Post-OP Ketorolac Ovarian , Fallopian Tube Primary Peritoneal Cancer</brief_title>
	<detailed_description>Ovarian cancer sixth common cancer seventh common cause cancer death woman across globe . The majority woman , nearly 70 % , present advanced stage disease herald poor prognosis . Despite aggressive treatment still favor initial debulking surgery follow platinum taxane base chemotherapy regimen , patient relapse achieve complete clinical response . Our group show ketorolac inhibit gene activity inhibits cell proliferation migration.Ketorolac use study goal produce specific inhibition cell adhesion migration ovarian cancer cell retrieve within peritoneal cavity cytoreductive surgery .</detailed_description>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>( PREOPERATIVE [ OP ] ) Patients must suspect diagnosis ovarian , fallopian tube primary peritoneal cancer plan cytoreductive surgery Borderline ovarian cancer ascites Eastern Cooperative Oncology Group ( ECOG ) /Zubrod/ Southwest Oncology Group ( SWOG ) performance status &lt; 2 ( Karnofsky performance status &gt; = 70 % ) Ability provide inform consent Absolute neutrophil count &gt; 1000/uL Platelet count &gt; 100'000/uL Serum creatinine = &lt; 1.5 x upper limit normal ( ULN ) Bilirubin = &lt; 1.5 x normal Serum glutamic oxaloacetic transaminase ( SGOT ) ( aspartate aminotransferase [ AST ] ) serum glutamic pyruvic transaminase ( SGPT ) ( alanine aminotransferase [ ALT ] ) level = &lt; 2 x ULN No known bleed disorder No known sensitivity nonsteroidal antiinflammatory drug ( NSAIDs ) No active peptic ulcer disease No active bleeding SECONDARY ELIGIBILITY Histologic diagnosis epithelial ovarian , fallopian tube primary peritoneal cancer frozen section diagnosis Placement intraperitoneal port time surgery anticipate use adjuvant chemotherapy management postoperative ascites If epidural catheter use catheter must remove prior treatment No active bleed Nonepithelial ovarian cancer metastatic cancer ovary Borderline ovarian cancer without ascites Presumed early stage ovarian cancer No clinical indication peritoneal port Active use epidural catheter Uncontrolled unstable medical condition Off study use ketorolac NSAIDs prior study administration Active bleed high risk bleed Active therapeutic anticoagulation Known hypersensitivity NSAIDs Chronic acute renal insufficiency define preoperative serum creatinine great 1.5mg/dL creatinine clearance &lt; 60 ml/min Any comorbid condition ' view attend physician ' render patient high risk treatment complication</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Ketorolac</keyword>
	<keyword>Bioavailability</keyword>
	<keyword>Pain</keyword>
</DOC>